Advancing Integrative Medical Care

Sunil Aggarwal, MD, PhD, FAAPMR is a Board-Certified Physician in Hospice and Palliative Medicine and Physical Medicine and Rehabilitation and Medical Geographer and serves as the Past Chair of the American Academy of Hospice and Palliative Medicine (AAHPM) Integrative Medicine Special Interest Group and an inaugural member of the Safe Use in Psychedelic-Assisted Therapies Forum.
He was recently named as a Top 20 Emerging Leader by the AAHPM. He is an Affiliate Assistant Clinical Professor in Rehabilitation Medicine at the University of Washington School of Medicine, an Affiliate Assistant Professor in the Department of Geography, and an Affiliate Clinical Faculty with Bastyr University. He completed his MD and PhD degrees at the University of Washington and Residency and Fellowship at Virginia Mason Medical Center, NYU Langone Health, and the NIH Clinical Center. He is a Co-founder, Co-director and practitioner at the Advanced Integrative Medical Science (AIMS) Institute in Seattle, a multispecialty teaching clinic and research institute offering cutting edge care in oncology, psychiatry, neurology, rehabilitation, pain, and palliative care. He also serves as an Associate Hospice Medicine Director and On-Call Palliative Physician for MultiCare Health System. He has published over three dozen peer-reviewed article and book chapters that have been cited over 800 times per Google Scholar.

8:32 Dr. Aggarwal describes the unique cancer care at the Advanced Integrative Medical Science (AIMS) Institute in Seattle.
13:50 Dr. Diva’s take on how this approach is revolutionary compared to the standard of cancer care.
18:48 How AIMS Institute’s approach translates to treating chronic conditions beyond cancer.
21:24 Dr. Aggarwal’s approaches to psycho-spiritual healing.
27:05 Dr. Aggarwal explains his utilization of ketamine-assisted therapies, and his legal efforts to expand patients’ access to other psychedelics including psilocybin.
32:58 Dr. Aggarwal’s perspective on how psychedelic therapies assist in overall healing and wellbeing.
36:59 The power of psychedelics as psychoplastogens—and the psychology of awe.
41:10 Discussing dosages for ketamine-assisted therapy.
44:13 The ongoing efforts to track how AIMS’ integrative approach compares to the current standards of care.
48:17 Contact info, and how to utilize the services of the AIMS Institute.

Links mentioned in this episode:
https://www.aimsinstitute.net/ (AIMS Institute Website)
https://www.facebook.com/aimsinstitutepllc/posts_to_page/ (Facebook)
https://www.instagram.com/aimsinstituteseattle/ (Instagram)
This episode is sponsored by http://www.getchews.com/ (TotumVos Collagen Chews).
You can find TotumVos at www.getchews.com.

*Use code DRDIVA for an additional 10% off your first order.

Leave a Reply

Latest Blog Posts

Proactive Breast Health: Self-Care and Self-Exam Tips for Breast Cancer Prevention

Proactive Breast Health: Self-Care and Self-Exam Tips for Breast Cancer Prevention

by Clinical Consulting Team This post was written by our guest author, Raushanah Najeeullah, ND. Breast cancer affects approximately one in eight women, making it one of the most common cancers worldwide. While genetic factors can influence breast cancer risk, lifestyle choices and early detection play an important role in prevention. Nutrient and hormone influences, and possibly estrogen metabolism, might be contributors to breast cancer development. Select use of testing and addressing results, could influence optimal breast health and may be associated with reducing breast cancer risk. The DUTCH Test (Dried Urine Test for Comprehensive Hormones) provides potential valuable insights ...

Read More
New Urine Test Reduces Unnecessary Biopsies in Prostate Cancer Detection

New Urine Test Reduces Unnecessary Biopsies in Prostate Cancer Detection

Author: Raushanah Najeeullah, ND A new urine test, MyProstateScore 2.0 (MPS2), offers better accuracy for detecting high-grade prostate cancer compared to current methods. In a recent study involving over 1,500 men, MPS2 reduced unnecessary biopsies by up to 51% while still identifying significant cancers with high sensitivity. This test improves on the PSA test by specifically targeting 17 genes linked to high grade aggressive prostate cancer, making it a promising non-invasive tool for reducing the risks and discomfort associated with prostate cancer screening. Source: Tosoian JJ, Zhang Y, Xiao L, et al. Development and Validation of an 18-Gene Urine Test ...

Read More
Brain cancer update

Brain cancer update

July 12, 2024 Leanna Standish IV CURCUMIN AIMS Institute’s integrative oncology team is investigating the therapeutic effects of intravenous curcumin in treating the most aggressive type of brain cancer, called glioblastoma.  Curcumin is the molecule present in turmeric root that has anticancer activity.  Curcumin has been shown in cell culture experiments to cause the programmed death of glioblastoma cells.  We use IV curcumin in order to provide sufficient levels of curcumin to the brain that will slow tumor growth.  Our brain cancer patients are enrolled in AIMS Institute’s IRB-approved study called the AIMS CANCER OUTCOMES STUDY.  Last year we presented ...

Read More
Call Us Text Us
Skip to content